Clinical trial
An Exploratory Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars in Real-world Practice
NCT04971304 is registered in ClinicalTrials.gov with Catherine M. Lockhart as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars in Real-world Practice
- Lead sponsor
- Catherine M. Lockhart
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2015
- Completion date
- December 31, 2022
- Enrollment
- 16,506 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of colon, cancer of pancreas, cancer, breast, cancer, lung, cancer, ovarian, lymphoma, non-hodgkin